Bioadaptives Stock Today
| BDPT Stock | USD 0.11 0.01 10.00% |
Performance13 of 100
| Odds Of DistressOver 72
|
BioAdaptives is selling for under 0.11 as of the 30th of January 2025; that is 10.00 percent increase since the beginning of the trading day. The stock's last reported lowest price was 0.1. BioAdaptives has a very high chance of experiencing financial distress in the next few years of operation. However, it had a very good returns during the last 90 days. The performance scores are derived for the period starting the 31st of December 2024 and ending today, the 30th of January 2025. Click here to learn more.
BioAdaptives, Inc. markets and distributes natural plant and algal-based products for humans and animals. BioAdaptives, Inc. was incorporated in 2013 and is based in Las Vegas, Nevada. Bioadaptives operates under Packaged Foods classification in the United States and is traded on OTC Exchange. The company has 160.49 M outstanding shares. More on BioAdaptives
Moving against BioAdaptives Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioAdaptives Pink Sheet Highlights
| Thematic Idea | Penny (View all Themes) |
| Business Concentration | Penny, Packaged Foods, Consumer Defensive (View all Sectors) |
BioAdaptives [BDPT] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Nano-Cap' category with a current market capitalization of 144.44 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioAdaptives's market, we take the total number of its shares issued and multiply it by BioAdaptives's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioAdaptives conducts business under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 160.49 M outstanding shares.
BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations.
Check BioAdaptives Probability Of Bankruptcy
Ownership AllocationBioAdaptives holds a total of 160.49 Million outstanding shares. BioAdaptives shows 7.4 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioAdaptives Ownership Details
BioAdaptives Risk Profiles
| Mean Deviation | 23.86 | |||
| Semi Deviation | 21.65 | |||
| Standard Deviation | 41.19 | |||
| Variance | 1696.43 |
BioAdaptives Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioAdaptives without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Forecasting Now
Equity ForecastingUse basic forecasting models to generate price predictions and determine price momentum |
| All Next | Launch Module |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.